Efficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy in Patients With CRCLM
Clinical trial NCT07728019 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07728019
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-22
- Primary completion
- 2029-06-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.